Sharman, J. P., Laurenti, L., Ferrant, E., Montero, L. F. C., Mulligan, S. P., Harrup, R., Opat, S., Ibatici, A., Marasca, R., Sportoletti, P., Thadani-Mulero, M., Cazares, O., Huang, W., Jiang, Y., Clark, E., Jin, H. Y., Boyer, M., Morschhauser, F. (2026). Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial. Blood. https://doi.org/10.1182/blood.2025030630